Cross-lineage expression of Ig-β (B29) in thymocytes:: Positive and negative gene regulation to establish T cell identity

被引:31
作者
Wang, H
Diamond, RA
Rothenberg, EV
机构
[1] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA
[2] CALTECH, Stowers Inst Med Res, Pasadena, CA 91125 USA
关键词
D O I
10.1073/pnas.95.12.6831
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Developmental commitment involves activation of lineage-specific genes, stabilization of a lineage-specific gene expression program, and permanent inhibition of inappropriate characteristics. To determine how these processes are coordinated in early T cell development, the expression of T and B lineage-specific genes was assessed in staged subsets of immature thymocytes, T lineage characteristics are acquired sequentially, with germ-line T cell antigen receptor-beta transcripts detected very early, followed by CD3 epsilon and terminal deoxynucleotidyl transferase, then pT alpha, and finally RAG1. Only RAG1 expression coincides with commitment. Thus, much T lineage gene expression precedes commitment and does not depend on it. Early in the course of commitment to the T lineage, thymocytes lose the ability to develop into B cells. To understand how this occurs, we also examined expression of well defined B lineage-specific genes. Although lambda 5 and Ig-alpha are not expressed, the mu(0) and I mu transcripts from the unrearranged IgH locus are expressed early, in distinct patterns, then repressed just before RAG1 expression. By contrast, RNA encoding the B cell receptor component Ig-beta was found to be transcribed in all immature thymocyte subpopulations and throughout most thymocyte differentiation. Ig-beta expression is down-regulated only during positive selection of CD4(+)CD8(-) cells. Thus several key participants in the B cell developmental program are expressed in non-B lineage-committed cells, and one is maintained even through commitment to an alternative lineage, and repressed only after extensive T lineage differentiation. The results show that transcriptional activation of "lymphocyte-specific" genes can occur in uncommitted precursors, and that T lineage commitment is a composite of distinct positive and negative regulatory events.
引用
收藏
页码:6831 / 6836
页数:6
相关论文
共 53 条
[1]   E2A PROTEINS ARE REQUIRED FOR PROPER B-CELL DEVELOPMENT AND INITIATION OF IMMUNOGLOBULIN GENE REARRANGEMENTS [J].
BAIN, G ;
MAANDAG, ECR ;
IZON, DJ ;
AMSEN, D ;
KRUISBEEK, AM ;
WEINTRAUB, BC ;
KROP, I ;
SCHLISSEL, MS ;
FEENEY, AJ ;
VANROON, M ;
VANDERVALK, M ;
TERIELE, HPJ ;
BERNS, A ;
MURRE, C .
CELL, 1994, 79 (05) :885-892
[2]   REGULATION OF RAG-1 AND CD69 EXPRESSION IN THE THYMUS DURING POSITIVE AND NEGATIVE SELECTION [J].
BRANDLE, D ;
MULLER, S ;
MULLER, C ;
HENGARTNER, H ;
PIRCHER, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (01) :145-151
[3]   INTRA-THYMIC AND EXTRA-THYMIC EXPRESSION OF THE PRE-T CELL-RECEPTOR ALPHA-GENE [J].
BRUNO, L ;
ROCHA, B ;
ROLINK, A ;
VONBOEHMER, H ;
RODEWALD, HR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (07) :1877-1882
[4]   Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes [J].
Carlyle, JR ;
Michie, AM ;
Furlonger, C ;
Nakano, T ;
Lenardo, MJ ;
Paige, CJ ;
ZunigaPflucker, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :173-182
[5]   ANOTHER VIEW OF THE SELECTIVE MODEL OF THYMOCYTE SELECTION [J].
CHAN, SH ;
COSGROVE, D ;
WALTZINGER, C ;
BENOIST, C ;
MATHIS, D .
CELL, 1993, 73 (02) :225-236
[6]  
CROSS MA, 1994, ONCOGENE, V9, P3013
[7]   BIPOTENTIAL PRECURSORS OF B-CELLS AND MACROPHAGES IN MURINE FETAL LIVER [J].
CUMANO, A ;
PAIGE, CJ ;
ISCOVE, NN ;
BRADY, G .
NATURE, 1992, 356 (6370) :612-615
[8]  
Diamond RA, 1997, J IMMUNOL, V158, P4052
[9]   Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci [J].
Ghia, P ;
tenBoekel, E ;
Sanz, E ;
delaHera, A ;
Rolink, A ;
Melchers, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2217-2229
[10]  
GODFREY DI, 1994, J IMMUNOL, V152, P4783